Zecotek’s 3D/2D Switchable Optical Imaging System for 3D Display Granted Korean Patent Allowance

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Korean Intellectual Property Office has granted a Notice of Allowance for its 3D/2D switchable optical imaging system for its glasses-free 3D auto-stereoscopic display system.

This Notice of Allowance adds to the other global patents, including U.S. patent number 7,944,465 covering Zecotek's glasses-free 3D auto-stereoscopic display system, as the Company moves to fully commercialize its innovative 3D technology and other photonics technology.

"As our 3D display technology gains prominence within the 3D industry, patent protection in leading technological nations, such as Korea, is key to protecting the underlying value of the technology," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. "Korea is home to the world`s major display manufacturers and to receive the notice of allowance in this important jurisdiction significantly strengthens our international patent protection with respect to our glasses-free 3D display technology. The patent grant from Korea is in addition to those patents granted in United States, China, Europe, Eurasia, Russia and Australia. We will continue to vigorously protect all of the Company`s underlying technology through patents and litigation where necessary."

Zecotek's 3D display system has significant competitive advantages compared to competing systems. The 3D/2D switchable optical imaging system further improves the core capabilities of the 3D display technology by introducing a software-selectable full-resolution 2D mode with viewing angles and dynamic range/colour depth on par with conventional 2D displays. The patent covers technology for both 3D and 2D modes, dynamic adjustment of viewing angle, number and width of viewing zones as well as the functionality to dynamically control the positioning of different viewing zones.

Zecotek has overcome the main technical barriers required for flat screen form, high definition display technologies, and the Company is looking to co-develop an OLED/LED (organic light emitting diode) based, flat screen, glasses-free, true 3D HD television with a strategic partner. There continues to be significant interest in the 3D industry for a replacement for display systems which require glasses or provide limited views.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Zecotek Photonics. (2019, February 26). Zecotek’s 3D/2D Switchable Optical Imaging System for 3D Display Granted Korean Patent Allowance. AZoOptics. Retrieved on December 06, 2024 from https://www.azooptics.com/News.aspx?newsID=18851.

  • MLA

    Zecotek Photonics. "Zecotek’s 3D/2D Switchable Optical Imaging System for 3D Display Granted Korean Patent Allowance". AZoOptics. 06 December 2024. <https://www.azooptics.com/News.aspx?newsID=18851>.

  • Chicago

    Zecotek Photonics. "Zecotek’s 3D/2D Switchable Optical Imaging System for 3D Display Granted Korean Patent Allowance". AZoOptics. https://www.azooptics.com/News.aspx?newsID=18851. (accessed December 06, 2024).

  • Harvard

    Zecotek Photonics. 2019. Zecotek’s 3D/2D Switchable Optical Imaging System for 3D Display Granted Korean Patent Allowance. AZoOptics, viewed 06 December 2024, https://www.azooptics.com/News.aspx?newsID=18851.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.